A recent study reaffirms that starting antiretroviral therapy soon after HIV diagnosis leads to faster viral suppression.
The latest update to official guidelines issued by the U.S. Department of Health and Human Services occurred within the adult/adolescent guidelines on June 3.
May 20, 2021: HIV testing and prevalence trends in the U.S.; groups at higher risk for losing viral suppression; intent vs. reality in making clinic appointments; transitioning from pediatric to adult HIV care.
A new study shows that almost two-thirds of older adults who were diagnosed with HIV at a Connecticut clinic were already at an advanced stage of disease progression.
Feb. 25, 2021: High HCV SVR among people using substances; geographic HIV care disparities among Black Americans; self-administered imiquimod vs. ASIL excision; PrEP uptake in syringe service programs.
W. David Hardy, M.D., discusses the takeaway messages for HIV care providers after a recent research paper found that a third of all people living with HIV reported never discussing U=U with their provider.
Oct. 1, 2020: HIV surveillance trends among U.S. MSM; health insurance and viral suppression; PrEP prescribing among motivated clinicians; PrEP sharing between MSM.
July 16, 2020: Starting HIV treatment during hospitalization for people who use drugs; type of substance use affects viral suppression odds; benefits of a cross-disciplinary medical support team; does STI recency dictate PrEP necessity for women?
June 25, 2020: 25 years of HOPS; successes of San Francisco’s test-and-treat program; missed opportunities to test people who inject drugs; how patient-provider trust can curb prescribing cascades.
Recent studies examine the role anal sex is playing in HIV rates and anal cancer among women.